Estate Counselors LLC Acquires New Holdings in Doximity, Inc. $DOCS

Key Points

• Estate Counselors LLC has invested $3.51 million in Doximity, acquiring 60,400 shares of the company's stock in the first quarter, according to a recent SEC filing.
• Shares of Doximity (NASDAQ: DOCS) opened at $64.41, with a market capitalization of $12.06 billion and a reported 15.2% increase in revenue compared to the previous year.
• In recent analyst reports, various firms have adjusted their target prices for Doximity, with Raymond James raising their target to $75.00 and maintaining an "outperform" rating.

Estate Counselors LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 60,400 shares of the company's stock, valued at approximately $3,505,000.

Other institutional investors have also made changes to their positions in the company. VSM Wealth Advisory LLC bought a new position in shares of Doximity in the first quarter valued at about $29,000. Allworth Financial LP raised its holdings in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after buying an additional 287 shares during the last quarter. National Bank of Canada FI bought a new position in shares of Doximity in the first quarter valued at about $33,000. Spire Wealth Management raised its holdings in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after buying an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group raised its holdings in shares of Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after buying an additional 309 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of research analyst reports. KeyCorp lifted their price target on Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Raymond James Financial lifted their price target on Doximity from $65.00 to $75.00 and gave the company an "outperform" rating in a report on Friday, August 8th. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a report on Monday, June 2nd. Bank of America boosted their price objective on Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Finally, JPMorgan Chase & Co. dropped their price objective on Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a report on Tuesday, May 27th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $66.21.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director directly owned 6,360 shares in the company, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,000 shares of company stock worth $2,140,940. 31.30% of the stock is currently owned by company insiders.

Doximity Stock Performance

NASDAQ:DOCS traded up $3.5630 on Friday, hitting $67.6930. 1,637,248 shares of the stock were exchanged, compared to its average volume of 2,323,116. The stock has a market capitalization of $12.68 billion, a price-to-earnings ratio of 67.69, a P/E/G ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 52 week low of $35.32 and a 52 week high of $85.21. The company's 50-day moving average price is $60.80 and its 200 day moving average price is $60.48.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity's quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.